These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. Neutel JM Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863 [TBL] [Abstract][Full Text] [Related]
26. Rationale for the use of very-low-dose combinations as first-line treatment of hypertension. Waeber B; Brunner HR J Hypertens Suppl; 2001 Nov; 19(4):S3-8. PubMed ID: 11848261 [TBL] [Abstract][Full Text] [Related]
29. [7 causes of therapy refractory hypertension]. Schumacher B MMW Fortschr Med; 2006 Mar; 148(13):6, 8. PubMed ID: 16642694 [No Abstract] [Full Text] [Related]
30. Current role of beta-blockers in the treatment of hypertension. Aronow WS Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702 [TBL] [Abstract][Full Text] [Related]
31. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril. Chatzikyrkou C; Haller H; Menne J Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194 [TBL] [Abstract][Full Text] [Related]
32. Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension? Chapman N; Chen CY; Fujita T; Hobbs FD; Kim SJ; Staessen JA; Tanomsup S; Wang JG; Williams B J Hypertens; 2010 Sep; 28(9):1796-803. PubMed ID: 20543713 [TBL] [Abstract][Full Text] [Related]
33. Outcomes from treatment. Clinical applications from recent trials. Howes LG Aust Fam Physician; 1999 Jul; 28(7):707-10. PubMed ID: 10431429 [TBL] [Abstract][Full Text] [Related]
35. [The treatment of the disease "hypertonia" based on the new recommendations]. Szegedi J Orv Hetil; 2005 Mar; 146(12):539-45. PubMed ID: 15853062 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacotherapy of arterial hypertension]. Demin AA Sov Med; 1981; (9):88-94. PubMed ID: 7313801 [No Abstract] [Full Text] [Related]
37. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension. Waeber B; Mourad JJ Am J Hypertens; 2006 Sep; 19(9):985-6. PubMed ID: 16942945 [No Abstract] [Full Text] [Related]
38. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905 [TBL] [Abstract][Full Text] [Related]
39. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492 [TBL] [Abstract][Full Text] [Related]
40. Initial combination therapy for rapid and effective control of moderate and severe hypertension. Franklin SS; Neutel JM J Hum Hypertens; 2009 Jan; 23(1):4-11. PubMed ID: 18615100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]